Skip Navigation
  Search Menu
Find an Expert

 

Amy Susan Duffield, M.D., Ph.D.

Photo of Dr. Amy Susan Duffield, M.D., Ph.D.

Assistant Professor of Pathology

Female

Expertise: Pathology

Research Interests: Leukemia, FLT-3; protein-protein interactions; diagnostic Hematopathology

Locations

The Johns Hopkins Hospital

401 North Broadway
Pathology, Weinberg Building, Suite 2242
Baltimore, MD 21231-2410 map

Background

Dr. Amy Duffield is an assistant professor of pathology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. Her areas of clinical expertise include pathology and hematopathology, with a particular focus on diagnosing hematopoietic neoplasms.

Dr. Duffield earned her M.D. and Ph.D. from the Yale University School of Medicine. She completed her residency at The Johns Hopkins Hospital and performed a fellowship in pathology at the Johns Hopkins Hospital.

Dr. Duffield's research interests include the study of novel protein-protein interactions. She is currently identifying and investigating the functional significance of proteins that interact with receptor tyrosine kinase FMS-Like Tyrosine kinase 3 (FLT3) in hematopoietic and leukemic cells.

...read more

Titles

  • Assistant Professor of Pathology
  • Assistant Professor of Oncology

Departments / Divisions

Education

Degrees

  • MD PhD, Yale School of Medicine (2005)

Residencies

  • Johns Hopkins University School of Medicine / Pathology (2009)

Fellowships

  • Johns Hopkins University School of Medicine / Pathology (2010)

Board Certifications

  • American Board of Pathology / Anatomic & Clinical Pathology (2009)
  • American Board of Pathology / Pathology - Hematology (2010)

Research & Publications

Research Summary

Dr. Duffield's research involves the study of novel protein-protein interactions. She is currently identifying and investigating the functional significance of proteins that interact with receptor tyrosine kinase FMS-like tyrosine kinase 3 (FLT3) in hematopoietic and leukemic cells.

Selected Publications

View all on Pubmed

Wu M, Hamaker M, Li L, Small D, Duffield AS. DOCK2 Interacts with FLT3 and Modulates the Survival of FLT3-Expressing Leukemia Cells. Leukemia. 2017 Mar;31(3):688-696

Crane GM, Samols MA, Morsberger LA, Yonescu R, Thiess ML, Batista DAS, Ning Y, Burns KH, Vuica-Ross M, Borowitz MJ, Gocke CD, Ambinder RA, Duffield AS. Tumor-Infiltrating Macrophages in Post-Transplant, Relapsed Classical Hodgkin Lymphoma are Donor-Derived. PLoS One. 2016 Sep 29;11(9):e0163559

Crane GM, Powell H, Kostadinov R, Rocafort PT, Rifkin DE, Burger PC, Ambinder RF, Swinnen LJ, Borowitz MJ, Duffield AS. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage. Oncotarget. 2015 Oct 20;6(32):33849-66

McCall CM, Mudali S, Arceci RJ, Small D, Fuller S, Gocke CD, Vuica-Ross M, Burns KH, Borowitz MJ, Duffield AS. Flow Cytometric Findings in Hemophagocytic Lymphohistiocytosis. Am J Clin Pathol. 2012; 137:786-794

Duffield AS, Aoki J, Levis M, Cowan K, Gocke CD, Burns KH, Borowitz MJ, Vuica-Ross M. Clinical and Pathologic Features of Secondary Acute Promyelocytic Leukemia. Am J Clin Pathol. 2012;137 367-376

Is this you? Edit Profile